Back to top

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema | IRIX Stoc

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

IRIDEX Corporation (IRIX)